当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
Nature Medicine ( IF 58.7 ) Pub Date : 2022-01-01 , DOI: 10.1038/s41591-021-01673-3
Hai-Qiang Mai , Qiu-Yan Chen , Dongping Chen , Chaosu Hu , Kunyu Yang , Jiyu Wen , Jingao Li , Ying-Rui Shi , Feng Jin , Ruilian Xu , Jianji Pan , Shenhong Qu , Ping Li , Chunhong Hu , Yi-Chun Liu , Yi Jiang , Xia He , Hung-Ming Wang , Wan-Teck Lim , Wangjun Liao , Xiaohui He , Xiaozhong Chen , Zhigang Liu , Xianglin Yuan , Qi Li , Xiaoyan Lin , Shanghua Jing , Yanju Chen , Yin Lu , Ching-Yun Hsieh , Muh-Hwa Yang , Chia-Jui Yen , Jens Samol , Hui Feng , Sheng Yao , Patricia Keegan , Rui-Hua Xu



中文翻译:

出版商更正:Toripalimab 或安慰剂加化疗作为晚期鼻咽癌的一线治疗:一项多中心随机 3 期试验。

更新日期:2022-01-13
down
wechat
bug